Universal Health Services (UHS) Financials

Universal Health Services (NYSE: UHS) has shown a generally favorable trend across the last four years, highlighted by rising revenue, improving profitability, and ongoing cash generation. While the company has retained leverage and stepped up capital investments, trends in earnings per share and operating margins point to continuing value creation for investors who can tolerate some near-term reinvestment spend.

The key multi-year themes include:

• Revenue growth and margin expansion: Operating revenue rose from roughly $3.45B in late 2022 to about $4.49B by Q4 2025, with gross margins expanding from the mid- to high-40s/50% range into the mid-50s percent over time. This implies better pricing/payer mix or volume trends and improved cost control at the gross profit line.
• Stronger earnings per share and net income: Net income attributable to common shareholders grew meaningfully, with diluted EPS rising from roughly $2.40–$3.00 range in 2023–2024 to about $7.01 (diluted) and $7.14 (basic) in Q4 2025, reflecting higher net income per share and stronger profitability.
• Healthy cash generation and free cash flow potential: Cash flow from continuing operating activities remained robust in the latest quarter (approximately $0.57B in Q4 2025), supporting ongoing capex and potential returns to shareholders. After adjusting for capital expenditures, free cash flow remained positive in the period, highlighting liquidity resilience.
• Shareholder returns and capital allocation: The company continued to return capital to shareholders, including notable share repurchases in late 2025, alongside a steady dividend per share of $0.20. These actions support per-share metrics and reflect a disciplined capital strategy.
• Capital expenditure and asset investment: Purchases of property, plant & equipment rose meaningfully (PE/PP&E capex) across multiple years, elevating depreciation and capital intensity but positioning the company for potential long-term growth and improved service capacity.
• Debt levels and funding mix: Long-term debt crept higher over the period (roughly moving toward the $5B mark by mid-2025), contributing to a higher leverage footprint. Interest expense remained a manageable cost driver, but higher debt levels warrant attention to funding costs and debt maturity profiles going forward.
• Operating cash flow momentum vs. prior years: While operating cash flow remained positive and sizable, quarterly CFO in Q4 2025 showed some variability versus prior quarters, reflecting seasonality and investment activity; the trend remains broadly constructive when viewed across the four-year window.
• Tax rate consistency: The company’s effective tax rate has hovered around the low-to-mid 20% range, offering a relatively predictable tax impact on earnings formation across years.
• Margin dynamics vs. SG&A levels: Selling, General & Administrative expenses have fluctuated as a percent of revenue, with some quarters showing higher SG&A loads in 2025. This could press margins in the near term if SG&A remains elevated relative to revenue growth.
• Near-term margin pressure from elevated SG&A in Q4 2025: SG&A expense rose to about $1.72B on revenue of roughly $4.49B in Q4 2025, implying a step up in operating costs that modestly dampens margin expansion compared with prior periods.